Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE: 002287)

Tibet Cheezheng Tibetan Medicine Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	2,265	2,040	2,040	1,766	1,480	1,401
Other Revenue	5.55	5.55	4.63	4.06	4.58	2.05
Revenue	2,271	2,045	2,045	1,770	1,485	1,403
Revenue Growth (YoY)	21.11%	0.02%	15.49%	19.22%	5.87%	15.62%
Cost of Revenue	400.73	324.7	325.52	269.7	217.36	182.11
Gross Profit	1,870	1,720	1,719	1,501	1,268	1,221
Selling, General & Admin	1,281	1,162	1,107	986.35	828.33	824.3
Research & Development	60.27	58.63	55.09	70.82	60.32	55.55
Other Operating Expenses	27.91	32.26	29.47	28.58	25.68	22.32
Operating Expenses	1,367	1,253	1,192	1,084	915.16	901.98
Operating Income	503	467.52	527.71	416.45	352.54	318.58
Interest Expense	-62.6	-63.07	-56.42	-53.43	-22.31	-4.67
Interest & Investment Income	2.99	41.92	16.96	340.33	58.1	34.34
Currency Exchange Gain (Loss)	-0.03	-0.03	-0.02	-0.02	-0.11	-0.04
Other Non Operating Income (Expenses)	0.54	-1.16	-3.56	-2.46	-0.98	-0.64
EBT Excluding Unusual Items	443.9	445.19	484.68	700.88	387.24	347.58
Impairment of Goodwill	-	-	-	-15.77	-	-
Gain (Loss) on Sale of Investments	76.25	37.07	-37.08	20.69	-	2.28
Gain (Loss) on Sale of Assets	0.12	0.32	0	-0.07	-0.35	1.81
Asset Writedown	-0.6	-0.3	-1.22	-0.35	-0.04	-0.01
Other Unusual Items	153.06	162.14	72.82	82.54	58.11	49.59
Pretax Income	672.72	644.41	519.2	787.91	444.96	401.26
Income Tax Expense	78.72	65.24	49.56	77.09	40.78	36.87
Earnings From Continuing Operations	594	579.18	469.64	710.83	404.18	364.39
Minority Interest in Earnings	0.07	2.02	2.9	5.05	-0.22	-0.14
Net Income	594.07	581.2	472.54	715.88	403.96	364.25
Net Income to Common	594.07	581.2	472.54	715.88	403.96	364.25
Net Income Growth	20.38%	22.99%	-33.99%	77.21%	10.90%	14.27%
Shares Outstanding (Basic)	530	530	530	529	529	528
Shares Outstanding (Diluted)	530	530	530	529	529	528
Shares Change (YoY)	0.00%	-0.05%	0.21%	0.12%	0.03%	-0.53%
EPS (Basic)	1.12	1.10	0.89	1.35	0.76	0.69
EPS (Diluted)	1.12	1.10	0.89	1.35	0.76	0.69
EPS Growth	20.38%	23.05%	-34.13%	77.01%	10.87%	14.88%
Free Cash Flow	475.77	458.59	13.29	909.35	-101.7	353.68
Free Cash Flow Per Share	0.90	0.87	0.03	1.72	-0.19	0.67
Dividend Per Share	0.480	0.480	0.390	0.590	0.340	0.350
Dividend Growth	23.08%	23.08%	-33.90%	73.53%	-2.86%	11.46%
Gross Margin	82.35%	84.12%	84.08%	84.77%	85.36%	87.02%
Operating Margin	22.15%	22.86%	25.81%	23.52%	23.74%	22.71%
Profit Margin	26.16%	28.42%	23.11%	40.43%	27.20%	25.97%
Free Cash Flow Margin	20.95%	22.42%	0.65%	51.36%	-6.85%	25.21%
EBITDA	590.18	550.09	604.13	476.77	396.33	354.61
EBITDA Margin	25.99%	26.90%	29.54%	26.93%	26.69%	25.28%
D&A For EBITDA	87.18	82.57	76.42	60.32	43.79	36.03
EBIT	503	467.52	527.71	416.45	352.54	318.58
EBIT Margin	22.15%	22.86%	25.81%	23.52%	23.74%	22.71%
Effective Tax Rate	11.70%	10.12%	9.55%	9.78%	9.17%	9.19%
Revenue as Reported	2,271	2,045	2,045	1,770	1,485	1,403
Advertising Expenses	-	-	-	-	-	3.39

Source: S&P Capital IQ. Standard template. Financial Sources.